Efficacy of combined teriparatide & denosumab vs. single-drug treatment for osteoporosis

Study Type:Therapy

OE Level Evidence:2

Journal Level of Evidence:N/A

Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)

J Clin Endocrinol Metab. 2016 May;101(5):2023-30

Contributing Authors: JN Tsai AV Uihlein SM Burnett-Bowie RM Neer NP Derrico H Lee ML Bouxsein BZ Leder

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

No credit card required

JOIN Forgot Password?

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.